key: cord-0840604-9dakoiuj
authors: de Alcantara Lemos, Janaina; Oliveira, Anna Eliza M.F.M.; Araujo, Raquel Silva; Townsend, Danyelle M.; Ferreira, Lucas Antonio Miranda; de Barros, Andre Luis Branco
title: Recent progress in micro and nano-encapsulation of bioactive derivatives of the Brazilian genus Pterodon
date: 2021-09-07
journal: Biomed Pharmacother
DOI: 10.1016/j.biopha.2021.112137
sha: 790a0b36dc50eaa79f077b3672ffa84abab86104
doc_id: 840604
cord_uid: 9dakoiuj

In the last few decades, utilization of medicinal plants by the pharmaceutical industry has led to the identification of many new bioactive compounds. The genus Pterodon, native of the Brazilian Flora, is known for the therapeutic properties attributed to its species, which are widely used in popular medicine for their anti-inflammatory, anti-rheumatic, tonic, and depurative properties. The intrinsic low water solubility of the plant derivatives from the genus, including diterpenes with vouacapane skeletons that are partially associated with the pharmacological activities, impairs the bioavailability of these bioactive compounds. Recent studies have aimed to encapsulate Pterodon products to improve their water solubility, achieve stability, increase their efficacy, and allow clinical applications. The purpose of this paper is to review recent research on the use of nanotechnology for the development of new products from plant derivatives of the Pterodon genus in different types of micro- and nanocarriers. Therapeutic properties of their different products are also presented. Finally, an update about the current and future applications of encapsulated formulations is provided.

the last two are endemic [53, 62] . The genus Pterodon comprises aromatic trees growing 6-18 m tall and may have alternating or opposite leaflets. Their flowers may be pink or violet with cryptosmara type fruits with well-developed wings, or not. Present in several Brazilian phytogeographic domains, the species are widely distributed in the various North regions (Rondônia e Tocantins), Northeast (Bahia, Ceará, Maranhão e Piauí), Midwest (Distrito Federal, Goiás, Mato Grosso do Sul e Mato Grosso), and Southeast (Minas Gerais e São Paulo) [24, 62] .

The literature reports that oils and extracts obtained from fruit or seeds of Pterodon genus have a large array of active compounds and are recognized for their therapeutic properties, being widely used in popular medicine [24, 49] . Furthermore, a growing scientific interest is observed not only in biological applications and activities, but also in a search for a renewable source of the sample, the seeds, and fruit of Pterodon species, in which the supply of drug, extracts or fractions would not be limiting. Moreover, use of native materials is sustainable and may improve ecological conservation efforts.

Phytochemical investigations on the extracts and oil of the fruits and seeds of the Pterodon species revealed the presence of compounds such as saponins, phenolics, and terpenes [63, 64] . There are several papers referring also to the isolation of di-and sesquiterpenes such as specific compounds of interest within this genus, according to their displayed effects and probably related to biological activities [46, 65] . Since the various substances in the class of terpenes are derived from mevalonic acid, their molecular structures are composed of variations of isoprene units (Fig. 2a) . Diterpenes contain four isoprene units in their basic structure and may be linear (i.e., geranylgeraniol) ( Fig. 2b) or cyclic with vouacapanic structure (also referred to as furan diterpenes) (Fig. 2c) [66] .

Other constituents, still of the terpene class, that have been identified as major components in the genus include the sesquiterpenes, with potential antioxidant activities and anti-inflammatory properties [36, 45, 53, 67] . Compounds from the essential oils of P. polygalaeflorus seeds, with a basic structure of three isoprene units such as βelemene, β-caryophyllene, and α-humulene (Fig. 3 ) are associated with anti-nociceptive, anti-inflammatory, and antispasmodic effects [41, 55, 68] .

Possible therapeutic targets of these compounds seem associated with suppression of proinflammatory cytokines (IL-1β, TNF-α, IL-6) and cell adhesion molecules (MCP-1) [76] [77] [78] .

In the 1960s, studies of the genus Pterodon started when Mors and colleagues demonstrated the chemoprophylactic efficacy of the P. pubescens fruit essential oil against Shistosoma mansoni cercariae [79] . Later, geranylgeraniol and 14,15-epoxigeranylgeraniol were isolated from the fruits of P. pubescens crude oil and the latter demonstrated prophylactic action against the trematode that causes schistosomiasis, by inhibiting the penetration of cercariae into the skin [80] .

Subsequently, studies revealed other activities such as the analgesic effect of oleaginous extracts obtained from Pterodon species [81] [82] [83] . Vouacapan derivatives 6α-7β-dihydroxyvouacapan-17β-oate [81] , 6α, 7β-Diacetoxyvouacapane [39] and 6α-7β-Dihydroxyvouacapan-17β-oic acid (DHVA) [43] were previously associated with this activity via activation of the catecholaminergic system or the involvement of central and peripheral opioidergic mechanisms [72, 81] . Oral administration of different doses of DHVA (50 and 100 mg/kg) inhibited the second phase of nociceptive behavior of the formalin test, which is dependent on peripheral inflammation and changes in central processing [43, 84] . However, there is no evidence that DHVA has any central anti-nociceptive activities. Other than the vouacapan derivatives, linear diterpenes geranylgeraniol and farnesol seem also to contribute to their analgesic actions, through modulation of inflammation [82] .

The hexane and methanol extracts of the fruits and seeds of Pterodon polygalaeflorus showed larvicidal activity against Aedes aegypti [47] . In this study, hexane extracts showed the best activity, which could be related to furanic diterpenes such as methyl 6α,7β-dihydroxyvouacapan-17β-oate, 6β-hydroxyvouacapan-7β, 17β-lactone, 6αacetoxyvouacapane and DHVA [47, 85] . Studies of antiproliferative activities in tumor cells of crude extracts of Pterodon seeds also were performed [39, 49, 86] . Furan diterpene rich fractions were able to induce DNA fragmentation, cell cycle arrest in the G1 phase, change in cyclin D1 and E2-expressing levels, increased cytochrome C release, and apoptosis induction in tumor cells [87, 88] .

The bioactive molecules of the genus Pterodon present in extracts, fractions, as well as the isolated compounds of the species are mostly substances with large hydrocarbon chains of low polarity with enormous structural diversity (Figs. 2 and 3), features that can limit bioavailability. To circumvent this problem, development of pharmaceutical nanotechnology-based formulations has been carried out [89] . Delivery systems from bioactive natural products are considered promising to increase therapeutic efficacy, mask the flavor of plant-derived product and protect it from possible degradation [90] [91] [92] . field, including industrial and biomedical applications [94] [95] [96] . One significant challenge in developing pharmaceutical products is low water solubility and limited cellular permeability. This limitation can be overcome using nanosystems, exemplified by such marketed products as the liposomal formulations encapsulating the antitumor drugs daunorubicin and cytarabine (Vyxeos®), doxorubicin (Doxil®), vincristine sulfate (Marqibo®), irinotecan (Onivyde®) or antifungal amphotericin (AmBisome®, Abelcet®, Amphotec®), as well as the polymer-based nanoparticles for encapsulating triptorelin (Trelstar™), certolizumab pegol (Cimzia®) and estradiol (Estrasorb®) formulations indicated to treat prostate cancer, moderate vasomotor symptoms and autoimmune inflammatory diseases, respectively [97, 98] .

Liposomes and polymer-based nanoparticles are the most advanced in terms of clinical translation, cancer therapy being the main application, which may reflect both the levels of funding in the area as well as the suitability of nanocarriers for the drug delivery of antineoplastic. In addition to the encapsulation of drug molecules, research has shown that lipid-based nanoparticles are interesting strategies for the encapsulation of oligonucleotides (RNA, mRNA, siRNA, and DNA) for the treatment and prevention of various diseases [99, 100] . Recently, there was FDA approval for Onpattro®, consisting of siRNA encapsulated in lipid nanoparticles for the treatment of polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis [101, 102] . Given the current situation regarding the SARS-CoV-2 pandemic scenario, the successful development and fast-tracking of nanotechnology-based vaccines as the delivery vehicle of messenger RNA (mRNA) and DNA have shown notable implications for the future of nanotechnology-enabled for drug and gene delivery. The safety and efficacy data of these nanosystems already available on the market can supply the foundation for the clinical translation on future therapeutic applications. Although each formulation has its challenges to face and overcome [103] .

As a drug transport and delivery system, nanocarriers in medicine are colloidal systems that contain an encapsulated active pharmaceutical ingredient (API), integrated into the particle core, or matrix, conjugated on the nanoparticle surface [104] . They can be used as a platform for the diagnosis, prevention, and/or treatment of several diseases [105] [106] [107] . Different systems can be used to encapsulate bioactive compounds. Due to their small size and the large surface area, leading to improved pharmacokinetics and site-specific delivery, nanoscale particles have shown promising drug delivery properties [104, 108] . In general, their applications aim to increase a drug's therapeutic index and safety profile, lowering the required doses used to achieve effective therapy. They, also, can be used to protect unstable substances in the face of early degradation or against possible instabilities in the biological environment. Furthermore, sustained drug release and increased cellular uptake are often associated with the use of nanosystems [89, 109] .

Nanostructured systems can be categorized as metallic, lipid, or polymeric [110] . Metallic nanoparticles have a core composed of alkali and noble metals [61, 111] . They can be classified as hard-nanoparticles whose central core is hardened and may limit drug-loading/ appending capacity to the particle's surface. Soft-nanoparticles refer to those materials whose central core is efficient for drug-loading and provide structural flexibility [112] . The polymeric and lipidic nanoparticles have flexible cores which can deform temporarily by de Alcantara Lemos et al. Page 6 stress or contact with surfaces [113] . Polymer-based nanoparticles are colloidal particles such as nanocapsules, and nanospheres where the drug can be encapsulated or adsorbed to the polymer [114, 115] . While lipid-based systems consist of a lipidic dispersion stabilized by surfactants (phospholipids, proteins, polysaccharides or minerals) and can be represented by liposomes, nano, or microemulsions, nanostructured lipid carriers [116] .

They can also be classified as passive or active targeting depending on how they target the desired tissue. In passive targeting, drug-loaded nanocarriers remain sufficiently long in circulation to accumulate in a desired tissue contingent on properties like size, pH, temperature, and charge [117, 118] . Drug accumulation in areas with leaky vasculature i. e., tumors, is also exploited for passively targeting [119, 120] . The aim is to get selective delivery of drugs into the site of action and low systemic toxicity. Alternatively, in the active targeting (or ligand-based targeting), a biological marker is attached to the nanocarrier surface to be recognized by receptors expressed in the target cell surfaces [119, 121] . This strategy is expected not only to improve the affinity and precision of the nanocarriers to the target cells/tissue but also to increase cell uptake [122, 123] . Active targeting can lead to better therapeutic effects. Some studies demonstrated that folate receptor-targeted liposomes loaded with antitumor drugs inhibited tumor growth [124, 125] . Liposomal formulations showed greater efficacy in MDA-MB-231 and 4T1 mouse models of metastatic breast cancer compared to individual components or current conventional formulations. Highlighting the efficiency of using active targeting for recognition, retention, and cell uptake after accumulation in the target region [126] [127] [128] [129] . The development of receptor-targeted systems could, therefore, significantly improve the delivery efficiency of drug-loaded nanocarriers.

For the administration of bioactive compounds from plants, nanosystems have been studied [130] . However, encapsulation of compounds and derivatives from the genus Pterodon has produced twenty-three (23) types of formulations that have been reported in the literature. As shown in Fig. 4 , nanoemulsions and microemulsions are the most prevalent, followed by polymeric particulate systems, magnetic/metallic, and nanoparticles nanostructured lipid carriers.

Throughout the literature, different combinations of drugs/bioactive ingredients of Pterodon spp. loaded in drug-delivery systems can be found and are listed in Table 1 .

Nanoemulsions are colloidal thermodynamically unstable dispersions of oil in water (O/W) or water in oil (W/O) stabilized by an interfacial film of surfactant molecules and sometimes co-surfactants [150] [151] [152] . Microemulsions can be differentiated as a colloidal thermodynamically stable dispersion. These nanosystems have the advantage of transporting high loads of lipophilic substances and also protect the encapsulated bioactives from hydrolysis, oxidation, or enzymatic degradation [153] . The main interest for using drug delivery systems based on microemulsions or nanoemulsions is to increase bioactive bioavailability [154, 155] . This incorporation can be accomplished through several methods, classified into two primary categories: high-energy and low-energy methods (Fig. 5) .

Nanoemulsions require the input of some external energy to convert the separate immiscible components into a dispersion. High-energy methods supply intense forces that disrupt and intermingle the oil and water phases resulting in tiny droplets with high kinetic energy. Mechanical devices such as ultrasonication or high-pressure homogenizers are generally used for nanoemulsion preparations [151, 156] . Nanoemulsions formulated through highenergy methods can therefore achieve high stability and small particle size. In contrast, lowenergy methods take advantage of the intrinsic physicochemical properties of formulation components that require a little addition of external energy to generate droplets. Phase inversion emulsification (emulsification methods) and self-emulsification are examples of low-energy approaches for the formation of micro and nanoemulsions. In principle, the process consists of mixing two liquid phases, one oily phase containing hydrophilic surfactant (plus drug) and an aqueous phase. When these two liquids are brought into contact, the surfactant molecules rapidly diffuse from the oily phase to the aqueous phase, which causes turbulence creating nano-sized emulsion droplets [154] . Currently, there is a focus on producing nano or microemulsions using low-energy methods once they are considered energetically efficient. In addition, it has a simple implementation and does not require sophisticated and expensive equipment [157] .

Once the thermodynamic instability of nanoemulsions is dependent on the preparation method, its optimization appears to be of fundamental importance for the development of successful delivery systems [156] and can lead to safer and more environmentally friendly practices.

Nanoemulsion is also an alternative for the delivery of hydrophobic compounds [158] . In order to increase the pharmacological efficacy of oily extracts from the genus Pterodon, several nanoemulsions (NE) have been developed. Among them, NE of the essential oil extracted from P. emarginatus. In this context, a study proposed the development of NE (O/W) with essential oils from P. emarginatus [131] . NE with the best results were prepared with essential oil and polysorbate 80 (1:1) in concentrations of 0.25% (wt/wt), using a simple organic solvent-free, low-energy method. NE containing essential oil from P. emarginatus fruits were able to induce mortality in Aedes aegypti larvae.

This larvicidal activity may be associated with β-caryophyllene, the main compound corresponding to 25.8% of the relative percentage in the oil. Valentim et al. [135] evaluated the in vitro antiparasitic activity of NE containing essential oil of P. emarginatus against monogenic parasites of the type Anacanthorus spathulatus, Notozothecium janauachensis, and Mymarothecium boegeri that usually infect the fish Colossoma macropomum. The in vitro results showed that NE containing the essential oils at concentrations from 100 to 600 mg/L had 100% antiparasitic activity. As the main constituents present in the essential oil of P. emarginatus are the compounds β-elemene, β-caryophyllene, and α-humulene, we can imply that they are responsible for biological activity. Recently, NE loaded P. emarginatus essential oil demonstrated high kinetic stability and was non-irritating, estimated by HET-CAM [40] . The results of this study can serve as a lead in determining in vivo therapeutic

properties of this nanoformulation.

The amber-colored oleoresin from P. emarginatus has been widely investigated, where the main components include the volatile essential oils made up of a mixture of terpenoids, e.g., the diterpenes with vouacapan skeleton and the non-volatile components [132] . P. emarginatus oleoresin) for larvicidal applications against Aedes aegypti and Culex quinquefasciatus, the main vector of dengue and lymphatic filariasis, respectively [45, 133] .

The NE were developed using a simple low-energy method with or without heating in solvent-free conditions, remaining stable during storage at room temperature when protected from light [45, 132, 133] . The formulations proposed in these studies for encapsulation of oleoresin showed activities (at 250-12.5 ppm, relative to oleoresin) against A. aegypti having a possible mechanism through the reversible inhibition of acetylcholinesterase [45] . Larvicidal activity against Culex quinquefasciatus, indicated morphological changes. However, unlike the larvicidal mechanism of action presented for A. aegypti, NE P. emarginatus oleoresin does not seem to inhibit acetylcholinesterase in C. quinquefasciatus larvae, and further studies are needed to evaluate possible mechanisms of action. In addition to evaluating the activity of a new product, it is essential to assess toxicological profiles, in this case, ecotoxicological risks. Exposing NE P. emarginatus oleoresin to an aquatic ecosystem using Chlorella vulgaris as a biological indicator, showed this formulation is potentially ecofriendly and non-toxic [133] .

Recently, NE prepared with oleoresin from the fruits of P. emarginatus showed antioxidant and chemoprotective activity, at 10 μg/mL, against ultraviolet (UV) radiation to human keratinocytes. These activities were related to the presence of phenolic compounds and terpenes present in the extracts of P. emarginatus. In parallel to the antioxidant effects, the NE managed to modulate the inflammatory profile of epithelial cells. A reduction in the levels of pro-inflammatory cytokines, IL-6 and IL-8, was observed in keratinocytes after UV irradiation [134] . Despite the high energy emulsification method and heating (at 65 °C) used to produce the nanoformulation, the oil activity was preserved.

The anti-inflammatory effects of P. emarginatus oleoresin from fruits Kawakami et al. Although both extracts have high cytotoxicity, supercritical extracts were more effective, showing superior inhibition against L. amazonensis promastigotes and amastigotes than extracts obtained by conventional methods. This fact is attributed to the high content of the geranylgeraniol derivative in supercritical extracts. Nanoemulsions showed a better index of selectivity and significant activity against parasite amastigotes Leishmania amazonensis (IC 50 : 2.7 ± 0.1 μg/mL for hexane extract nanoemulsion and IC 50 : 1.9 ± 0.3 μg/mL for supercritical fluid extract nanoemulsion). The findings of this study show that the developed NE promotes a drastic decrease in the IC 50 and increase in the selectivity index [137] . In the search for an efficient topical application system, the incorporation of hyaluronic acid in NE with P. pubescens fruit extract-loaded was also evaluated and showed an improvement of rheological properties. The addition of the cross-linked biomaterial resulted in increased viscosity and stability, which might facilitate topical applications [141] .

Nanoemulsions containing optimized P. pubescens ethanolic extracts of the fruits were developed by Hoscheid et al. [138] . To assess their efficiency and safety, another study by the same group [139] , evaluated the anti-inflammatory activities of NE in a model of carrageenan-induced peritonitis. The NE containing ethanolic extracts of P. pubescens showed a significant inhibitory effect on leukocyte migration, even after 1 year of storage, indicating potential use in anti-inflammatory therapies, as well as in the treatment of arthritis [142] . The anti-inflammatory potential of the oil extracted from the fruits of P. emarginatus and encapsulated in microemulsions was evaluated in the ear edema model induced by the topical application of croton oil [140] . Both the oil extracted and the proposed microemulsion system showed anti-inflammatory potential. However, the microemulsion was more efficient, possibly due to dermal or transdermal permeability improvements [159] .

Fundamental differences between micro and nanoemulsion surround the free energy of the system, giving them distinct characteristics in preparation, formulation and stability [160] . However, the use of microemulsions for bioactive compound delivery can be limited by the high concentrations of surfactants, since these agents, at certain levels, might be irritatants [161, 162] . On the other hand, nanoemulsions can be potential alternatives in this case since lower concentrations of surfactant are needed when compared to microemulsions [163] .

Polymeric particles have been extensively researched as delivery systems. Data in the literature have shown that such systems can modify pharmacokinetics and improve the therapeutic index of many drugs [164] . Some of the advantages of using polymeric systems include easy production, the facility to obtain a solid form that is more stable and marketable, controlled and sustained drug release, ability to modify surfaces with ligands for targeted drug delivery [165] . Differences between micro and nanoparticles relate to their size in micrometers and nanometers, respectively. For structural organization, they can be classified as spheres and capsules. The spheres are formed by a polymeric matrix, where the lipophilic and/or hydrophilic drug can be retained (solubilized or dispersed). The capsules are vesicular systems in which a polymeric wall surrounds the oily liquid core. In this case, the lipophilic drug is usually dissolved in the core, but may also be adsorbed to the polymeric surface [166, 167] .

Countless synthetic or natural polymers can be used for the development of polymeric nanoparticles. The release profile of the compound can be modulated according to its hydro and lipophilic properties and the nature of the polymers used in the development of the systems [168, 169] . Natural polymers, such as polysaccharides e.g., chitosan, dextran, are well known for their benefits in biodegradability and their negligible toxicity. On the other side, customizable degradation rates and physical and mechanical characteristics benefit synthetic polymers compared to natural polymers. The polymers most commonly used in the production of these carriers are aliphatic polyesters such as polyglycolic acid (PGA), polylactic acid (PLA), poly-lactic-co-glycolic acid (PLGA), and poly--ε-caprolactone (PCL) due to biocompatibility and biodegradability [170, 171] .

de Alcantara Lemos et al. Page 10 In order to produce microcapsules, the most common techniques used for encapsulation of oils are spray-drying and coacervation [172, 173] . Spray-drying is well-established to produce microparticles by atomizing the liquid suspension into a fine spray-dried by a stream of hot air. This method provides stable dehydrated products in the form of fine powders [174] . The principle behind the coacervation process involves the precipitation of polymers around of active compound, thus encapsulating it. With specific environmental influence (ionic strength, pH, or temperature variation), the liquid phase separates from the polymer-rich (coacervate) phase, forming microspheres or core-shell structured microcapsules [174, 175] . This method offers an advantage for encapsulating heat-sensitive compounds. However, depending on the polymer used, a high amount of organic solvent might be required, requiring subsequent evaporation from the product [176, 177] . In some cases, the encapsulation by the spray-drying process may be preferred to the coacervation method, as no organic solvents are needed within the preparation and is associated with low process costs allowing large-scale production in a continuous mode [177] . Different polymeric systems were developed from natural or synthetic polymers for the encapsulation of phytochemicals or plant extracts of Pterodon species (Fig. 6 ), in search of potential therapeutic interventions for future use in many diseases.

The first study to develop polymeric particulate systems employing derivatives of the genus Pterodon was reported by Servat et al. [143] . Microcapsules were produced by spray-drying of the biopolymers maltodextrin and gum arabic and the crude extract or vouacapan mixture (6α-hydroxy-7β-acetoxy-vouacapan-17β-oate methyl ester and 6α-acetoxy-7β-hydroxy-vouacapan-17β-oate methyl). Antinociceptive activity after i.p. administration of microcapsules with the crude extract or the vouacapan mixture was confirmed. Subsequently, a study by Alves et al. [44] evaluated the influence of different spray-drying parameters (as dryer inlet and flow injection) and excipient proportions on the production and the stability of microcapsule produced with P. emarginatus essential oil. Thus, the proposed system produced microcapsules around 5 μm with encapsulation efficiency higher than 90% and increased stability, in addition to solving the inconvenience of poor water solubility [44, 143] . In another study, Reinas et al. [90] microcapsules with oleaginous fractions were obtained from an alcohol extract from the fruits of P. pubescens using alginate/chitosan polymers of different molecular weights. Diameters of the microcapsules were between 0.4 and 1.0 μm. The best formulation prepared with alginate and low-molecular-weight chitosan presented high encapsulation efficiency of about 99,5% for vouacapanes methyl 6α-acetoxy-7β-hydroxyvouacapan-17β-oate and methyl 6α-hydroxy-7β-acetoxyvouacapan-17β-oate. Furthermore, in vitro release profile of the vouacapanes-loaded microcapsules was close to 75% (acid pH) after 24 h. Recently, PCL-based nanofibers associated with the ethanolic extracts from P. pubescens fruits were developed and showed potential in vitro activity in wound-healing assays. The extract could inhibit acute inflammatory actions attributed to the presence of voaucapans, limiting the phases of pain response and edema formation [144] .

Among the various nanosystems, magnetic iron oxide nanoparticles stand out for their high surface area and specific properties related to their magnetism [178, 179] . Various de Alcantara Lemos et al. Page 11 methods have been reported for the synthesis of iron oxide magnetite (Fe 3 O 4 ) or maghemite (γ-Fe 2 O 3 ) nano-particles. The most common include sol-gel synthesis, co-precipitation, micro-emulsion, and hydrothermal synthesis. However, co-precipitation has advantages of low cost, high product purity, and organic solvent-free conditions, presenting great potential for applications in several technological areas [180] .

Silveira et al. [145] proposed the development of maghemite nano-particles conjugated with sucupira seed resins produced by co-precipitation methods, without the need for expensive equipment or organic solvents. Molecular traces of iron oxide in the resins extracted from sucupira seeds expressed semiconductor characteristics. This system could be further investigated regarding more improved preparation methods and characterization [145] . In addition, the potential applications of maghemite nanoparticles directed against a specific target with the use of an external magnetic field combined with bioactive sucupira resin are of potential interest [181] . More studies are needed on the phytochemical characterization of the resins extracted from the sucupira seeds and the development of colloidal systems with ideal physicochemical characteristics for application in vivo [182, 183] . Preparation of promising delivery systems phytochemicals-based or plant extracts have also been employed successfully to generate metal nanoparticles with enhanced antimicrobial property ( Fig. 7 ) [184, 185] . Within this context, recently Oliveira et al. [146] synthesized silver nanoparticles using aqueous extracts of P. emarginatus (AgNPs-PE). Similarly, Toledo et al.

[147] demonstrated bactericidal and fungal activity of AgNPs-PE when associated with 1% gentamicin sulfate (AgNPs-PEG) and hyaluronic acid (AgNPs-PEG-AH2).

NLCs are systems formed by mixing solid and liquid lipids (oils), generating a less structured lipid matrix with imperfections that lead to greater accommodation of bioactive compounds, stabilized in water solution by surfactants [186] . The NLCs have been developed to enhance the encapsulation efficiency and prevent the expulsion of the drug during storage, a condition that usually can occur with solid lipid nanoparticles [187] .

Its advantages compared to other nanosystems include the absence of organic solvents for their production and the ability to modulate the release profile of the encapsulated bioactive compound [188] . Furthermore, lipid nanocarriers can be produced with natural lipids that have the advantage of inherent biological activity [189] . Developed as a promising alternative for liposomes and nano-emulsions, NLCs show advantageous features such as the use of low-cost excipients, ease of preparation, and high-scale production [190] . In this process, different methods have been developed and modified to produce NLCs under stable conditions, capable of reaching the specific target. In general, the most common methods used to manufacture these nanosystems can be divided into three different approaches. The first involves high-energy methods such as high shear homogenization and/or ultrasound techniques performed at elevated temperatures (hot homogenization) or below room temperature (cold homogenization). This approach has the advantage of being a highly effective dispersion technique for large-scale production. The cold homogenization further includes advantages as an absence of drug degradation by temperature or crystalline modification. The second approach involves low-energy methods, in which the commonly used technique is microemulsion formation. The advantage of this method is producing de Alcantara Lemos et al. Page 12 NLCs spherical and narrow in size [191] . The solvent emulsification-evaporation technique is a third approach for obtaining NLCs [191] . The technique consists of mixing an organic containing oil phase (liquid lipid + solid lipid) and drug dissolved in an organic solvent (water-immiscible) with an aqueous phase. This process allows the formation of nanodispersions, followed by evaporating the organic solvent causing precipitation of lipid nanoparticles in the aqueous phase. Through this method, small and monodisperse particles are obtained with high encapsulation efficiency [192] . However, the drawback of the method is the use of organic solvents, potentially leading to toxicity issues [191] .

Outuki et al. [148] optimized the development of NLCs containing P. pubescens fruit oil that provided promising activities against human colon adenocarcinoma cell line in vitro. In this study, the NLCs formulation containing 5% Precirol® ATO 5, 0.5% P80H, 2.5% PEG-40H castor oil as an aqueous surfactant, and 2% P. pubescens oil presented the best physicochemical characteristics. The authors showed that NLC formulations encapsulating P. pubescens oil were more effective against HT-29 cells when compared to the free oil, associating the efficiency improvement with the higher cellular uptake of the NLCs. Therefore, a well-designed controlled release system may enhance target specificity, optimizing the activities of compounds perhaps implying further application in colorectal cancer therapy.

The essential oils from fruits of the genus Pterodon was also encapsulated in NLCs by [149] .

The optimized NLCs in this study consisted of 0.5% (wt/vol) essential oil of Pterodon, 4.5%

(wt/vol) of glycerol monostearate as a solid lipid, and 1.4% (wt/vol) polyethylene glycol succinate D-α-tocopherol as surfactant. Using Franz diffusion cells, the release kinetics followed first-order, where the variation in concentration over time depends only on the concentration of sucupira oil encapsulated in the NLCs. Additional bioavailability studies are still required, in addition to in vivo efficacy.

The development of Pterodon genus-derived bioactive-loaded NLC has been extensively investigated showing promising results as drug delivery systems for the treatment of various diseases (Fig. 8 ).

The search for new therapeutic alternatives using flora provides a valuable outlet for new drug discovery in the pharmaceutical industry. However, many new drug molecules have poor water solubility. Overcoming such solubility and/or permeability barriers can be achieved using drug delivery systems such as nano-and micro-structured systems. In this review, we stress the capacity for particulate carriers to encapsulate vegetal derivatives, and detail how their use has shown promising biological activities. This serves to highlight the benefits of encapsulating extracts, oils, and bioactive compounds of the genus Pterodon in lipid, polymeric, and hybrid diverse particulate systems with desired performance and functionality. However, such approaches are mostly at the fundamental research stage still focused on the development of micro and nanostructured systems to overcome some potential challenges related to stability, solubility, and bioavailability. Therefore, there are currently no Pterodon genus-derived encapsulated formulations in clinical trials or of information about their mechanisms of action and toxicities. Even though particulate carriers have been studied with respect to their application of the genus Pterodon, there is a requirement for more robust in vivo studies. These could provide a platform for further development of safe and effective therapies using these natural product extracts. Chemical structure of some of the main sesquiterpene compounds isolated from the essential oil seeds and fruits of the genus Pterodon. Schematic illustration of the high-energy and low-energy methods for obtaining micro and nano-emulsion. Schematic illustration of the association between plant extracts or phytochemicals and their possible biomedical application. 

The value of plants used in traditional medicine for drug discovery

The polypharmacology of natural products

Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies

Medicinal plants: traditions of yesterday and drugs of tomorrow

The world medicines situation 2011: traditional medicines: global situation, issues, and challenges

Natural products as sources of new drugs from 1981 to

The role of natural products in modern drug discovery

Natural products in drug discovery: advances and opportunities

Natural products in drug discovery

Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

Discovery and resupply of pharmacologically active plant-derived natural products: a review

The aspirin story -from willow to wonder drug

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production

The safety of digoxin as a pharmacological treatment of atrial fibrillation

Digoxin: a systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction

Doing without codeine: why and what are the alternatives?

The quest for a practical synthesis of morphine alkaloids and their derivatives by chemoenzymatic methods

An investigation of the antiviral activity of Podophyllum peltatum

Podophyllotoxin acetate triggers anticancer effects against nonsmall cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy

Principles of early drug discovery

Synthesis of 6alpha,7beta-dihydroxyvouacapan-17beta-oic acid derivatives. Part IV: mannich base derivatives and its activities on the electrically stimulated Guinea-pig ileum preparation

Anti-inflammatory activity of the crude extract from the fruits of Pterodon emarginatus Vog

Sucupira as a potential plant for arthritis treatment and other diseases

Triterpenes involved in the anti-inflammatory effect of ethanolic extract of Pterodon emarginatus Vogel stem bark

The isoflavones of Pterodon pubescens

Isoflavones from Pterodon apparicioi

Isoflavonoids and triterpenoids isolated from Pterodon polygalaeflorus

Evaluation of antimicrobial activity of crude ethanol extract from the bark of "sucupira branca" (Pterodon emarginatus Vogel) -Fabaceae, Rev. Bras

Chemical composition, antimicrobial activity of essential oil and the occurrence of steroids in the leaves of Pterodon emarginatus Vogel

Preliminary phytochemical and antileishmanial studies of the ethanolic extracts of Pterodon pudescens, Rev. Bras

Diterpenoids from Pterodon polygalaeflorus

Sesquiterpenes and other contituents from leaves of Pterodon pubescens Benth (Leguminosae)

Chemical variability of the essential oils from fruits of Pterodon emarginatus in the Brazilian Cerrado

Pterodon pubescens oil: characterisation, certification of origin and quality control via mass spectrometry fingerprinting analysis

Chemical composition and cytotoxicity activity of the essential oil of Pterodon emarginatus

Inhibitory effect of the hexane fraction of the ethanolic extract of the fruits of Pterodon pubescens Benth in acute and chronic inflammation

Vouacapane diterpenoids isolated from Pterodon and their biological activities

Furanoditerpenes from Pterodon pubescens benth with selective in vitro anticancer activity for prostate cell line

Preparation of non-toxic nano-emulsions based on a classical and promising Brazilian plant species through a low-energy concept

Antispasmodic effects of essential oil of Pterodon polygalaeflorus and its main constituent β-caryophyllene on rat isolated ileum

Oil from the fruits of Pterodon emarginatus Vog.: a traditional anti-inflammatory. Study combining in vivo and in silico

Anti-inflammatory and analgesic effects of 6α,7β-dihydroxy-vouacapan-17β-oic acid isolated from Pterodon emarginatus Vog. fruits

Microencapsulation of essential oil from fruits of Pterodon emarginatus using gum arabic and maltodextrin as wall materials: composition and stability

Development of a larvicidal nanoemulsion with Pterodon emarginatus vogel oil

New diterpenoids from Pterodon emarginatus vog

Phytotochemical study and evaluation of larvicidal activity of Pterodon polygalaeflorus Benth (Leguminosae) against "Aedes aegypti

Braz-Filho R, Further diterpenoids isolated from Pterodon polygalaeflorus

Antiproliferative activity of Pterodon pubescens Benth. seed oil and its active principle on human melanoma cells

Antinociceptive effect of geranylgeraniol and 6alpha,7beta-dihydroxyvouacapan-17beta-oate methyl ester isolated from Pterodon pubescens Benth

Antinociceptive properties of ethanolic extract and fractions of Pterodon pubescens Benth. seeds

Suppression of T and B cell responses by Pterodon pubescens seeds ethanolic extract

Oleaginous extract from the fruits Pterodon pubescens Benth induces antinociception in animal models of acute and chronic pain

Development and characterization of poly(lactic-co-glycolic) acid nanoparticles loaded with copaiba oleoresin

Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation

Plant extracts: from encapsulation to application

The impact of nanobiotechnology on the development of new drug delivery systems

Nanocarriers: promising vehicle for bioactive drugs

Nanotech approaches to drug delivery and imaging

The emerging nanomedicine landscape

Therapeutic nanoparticles and their targeted delivery applications

Pterodon in Flora do Brasil 2020, Jard. Botânico Do Rio Janeiro

Antinociceptive activity of the HPLC-and MS-standardized hydroethanolic extract of Pterodon emarginatus Vogel leaves

A green protocol for microwave-assisted extraction of volatile oil terpenes from Pterodon emarginatus Vogel. (Fabaceae)

Medicinal plants in Brazil: pharmacological studies, drug discovery, challenges and perspectives

Medicinal Natural Products: A Biosynthetic Approach, Third

Radical scavenging and antimicrobial activities of Croton zehntneri, Pterodon emarginatus and Schinopsis brasiliensis essential oils and their major constituents: estragole, trans -anethole, βcaryophyllene and myrcene

Essential oil of Pterodon polygalaeflorus Benth attenuates nociception in mice

Successful treatment of collagen-induced arthritis in mice with a hydroalcohol extract of seeds of Pterodon pubescens

Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis

Subacute toxicity evaluation of a hydroalcoholic extract of Pterodon pubescens seeds in mice with collagen-induced arthritis

Evidence of the involvement of biogenic amines in the antinociceptive effect of a vouacapan extracted from Pterodon polygalaeflorus Benth

Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study

Inhibitory effects of Pterodon emarginatus bean oil and extract on Staphylococcus aureus

Antiulcerogenic and antiinflammatory activities of the essential oil from Pterodon emarginatus seeds

The combination of catechin, baicalin and β-caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro

β-elemene inhibits monocyteendothelial cells interactions via reactive oxygen species/MAPK/NF-κB signaling pathway in vitro

Elemene attenuates atherosclerosis in apolipoprotein E-deficient mice via restoring NO levels and alleviating oxidative stress

Ação profilática do óleo dos frutos de sucupira branca, Pterodon pubescens Benth. contra a infecção pelo Schistosoma mansoni

Chemoprophylactic agent in Schistosomiasis: 14,15-epoxygeranylgeraniol

Possible participation of endogenous opioid peptides on the mechanism involved in analgesia induced by vouacapan

Acute and topic anti-edematogenic fractions isolated from the seeds of Pterodon pubescens

Alves Costa E, Anti-inflammatory and anti-nociceptive effects of Pterodon emarginatus stem bark alcohol extract

The formalin test: an evaluation of the method

Larvicidal diterpenes from Pterodon polygalaeflorus, Vector Borne Zoonotic Dis

Effect of 6α,7β-dihydroxyvouacapan-17β-oic acid and its lactone derivatives on the growth of human cancer cells

Terpenic subfraction of Pterodon pubescens induces apoptosis of K562 leukemic cells by modulating gene expression

Antitumor screening of Pterodon pubescens terpenic fraction indicates high sensitivity for lymphocytic leukemia cells

Applications of novel drug delivery system for herbal formulations

Preparation and characterization of microcapsules of Pterodon pubescens Benth. by using natural polymers, Braz

Nanotechnology-based drug delivery systems and herbal medicines: a review

Advances in nanotechnologybased delivery systems for curcumin

Over a Decade of Progress and Innovation, A Rep. by U.S Food Drug Adm

How interdisciplinary is nanotechnology?

Nanotechnology: convergence with modern biology and medicine

Advances and challenges in nanocarriers and nanomedicines for veterinary application

Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities

Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects

Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement, acsnano.1c04996

Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines

On the role of helper lipids in lipid nanoparticle formulations of siRNA

Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine

Role of nanotechnology in targeted drug delivery and imaging: a concise review

Personalized nanomedicine: a revolution at the nanoscale

Emerging role of radiolabeled nanoparticles as an effective diagnostic technique

Theranostic nanomedicine; a next generation platform for cancer diagnosis and therapy

Effects of size and aggregation/agglomeration of nanoparticles on the interfacial/interphase properties and tensile strength of polymer nanocomposites

Liposomes as nanomedical devices

Nanotechnology-based drug delivery systems for enhanced diagnosis and therapy of oral cancer

Metal Nanoparticles for Drug Delivery and Diagnostic Applications

Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging

Nanoparticles in dermatology

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Polymer nanoparticles: preparation techniques and size-control parameters

Lipid based nanocarriers: a translational perspective

Nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid as a theranostic agent: evaluation of biodistribution and antitumor activity in experimental model

Doxorubicinloaded pH-sensitive micelles: a promising alternative to enhance antitumor activity and reduce toxicity

Passive and active tumour targeting with nanocarriers

Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model

Synthesis of cholesterol-based neoglycoconjugates and their use in the preparation of liposomes for active liver targeting

Liposomal drug delivery systems: from concept to clinical applications

Therapeutic potential of targeted nanoparticles and perspective on nanotherapies

Paclitaxel-loaded folate-coated pH-sensitive liposomes enhance cellular uptake and antitumor activity

Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model

Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: a biodistribution study

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology

Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress

Progress and challenges towards targeted delivery of cancer therapeutics

Natural product-based nanomedicine: recent advances and issues

Essential oil from Pterodon emarginatus as a promising natural raw material for larvicidal nanoemulsions against a tropical disease vector

Utilization of dynamic light scattering to evaluate Pterodon emarginatus oleoresin-based nanoemulsion formation by non-heating and solvent-free method

Pterodon emarginatus oleoresin-based nanoemulsion as a promising tool for Culex quinquefasciatus (Diptera: Culicidae) control

Protective effect of sucupira oil nanoemulsion against oxidative stress in UVA-irradiated HaCaT cells

Nanoemulsion from essential oil of Pterodon emarginatus (Fabaceae) shows in vitro efficacy against monogeneans of Colossoma macropomum (Pisces: Serrasalmidae)

Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis

Optimization of extraction method and evaluation of antileishmanial activity of oil and nanoemulsions of Pterodon pubescens benth. fruit extracts

Development and characterization of Pterodon pubescens oil nanoemulsions as a possible delivery system for the treatment of rheumatoid arthritis

Pterodon pubescens oil nanoemulsions: physiochemical and microbiological characterization and in vivo anti-inflammatory efficacy studies

Microemulsion based on Pterodon emarginatus oil and its anti-inflammatory potential, Braz

Hyaluronic acid incorporation into nanoemulsions containing Pterodon pubescens Benth. Fruit oil for topical drug delivery

Rheological behavior and antiarthritic activity of Pterodon pubescens nanoemulsion, e179108119

Pterodon pubescens benth: stability study of microencapsulated extract and isolated compounds monitored by antinociceptive assays

Electrospun PCL-based nanofibers Arrabidaea chica Verlot -Pterodon pubescens Benth loaded: synergic effect in fibroblast formation

Preparation of nanocomposites resin from seed Pterodon emarginatus doped maghemite nanoparticles

Synthesis of silver nanoparticles using aqueous extracts of Pterodon emarginatus leaves collected in the summer and winter seasons

Biosynthesis and characterization of silver nanoparticles produced with aqueous extract of Pterodon emarginatus Vogel -Fabaceae seeds associated with gentamicin sulfate and hyaluronic acid with potential antimicrobial activity

The incorporation of Pterodon pubescens fruit oil into optimized nanostructured lipid carriers improves its effectiveness in colorectal cancer

Sucupira oil-loaded nanostructured lipid carriers (NLC): lipid screening, factorial design, release profile, and cytotoxicity

Microemulsions: a novel approach to enhanced drug delivery, Recent Pat

Nanoemulsions: formation, properties and applications

Spontaneous emulsification

Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications

Nano-emulsions and micro-emulsions: clarifications of the critical differences

Biomedical applications of microemulsion through dermal and transdermal route

Nanoemulsions versus microemulsions: terminology, differences, and similarities

Techniques for formulation of nanoemulsion drug delivery system: a review

Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: influence of formulation parameters on polymethoxyflavone crystallization, Food Hydrocoll

Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery

Green micro-and nanoemulsions for managing parasites, vectors and pests

Surfactant-induced stratum corneum hydration in vivo: prediction of the irritation potential of anionic surfactants

Stratum corneum lipid removal by surfactants: relation to in vivo irritation

Formation and stability of nano-emulsions

Polymer-drug conjugate therapeutics: advances, insights and prospects

Polyester based polymeric nano and microparticles for pharmaceutical purposes: a review on formulation approaches

Polymeric Nanocapsules as Drug Delivery Systems

Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration

Polymeric nanoparticles for drug delivery

Polymeric nanoparticles for drug delivery: recent developments and future prospects

Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration

Encapsulation of polyphenols -a review

Microencapsulation of oils: a comprehensive review of benefits, techniques, and applications

Spray drying for the encapsulation of oils-a review

Spray drying of pharmaceuticals and biopharmaceuticals: critical parameters and experimental process optimization approaches

Biopolymer-based nanoparticles and microparticles: fabrication, characterization, and application

Antal I, Microparticles, microspheres, and microcapsules for advanced drug delivery

Spray-drying microencapsulation of anthocyanins by natural biopolymers: a review

Magnetic nanoparticles for gene and drug delivery

Advances in magnetic nanoparticles for biomedical applications

Synthesis and characterization of maghemite nanopowders by chemical precipitation method

Long-circulating and target-specific nanoparticles: theory to practice

Best practices for characterization of magnetic nanoparticles for biomedical applications

Magnetic nano particles: biomedical applications and challenges

Natural nanoparticles: a particular matter inspired by nature

Medicinal plant leaf extract and pure flavonoid mediated green synthesis of silver nanoparticles and their enhanced antibacterial property

Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

Lipid nanoparticles for parenteral delivery of actives

Development of nanoparticles from natural lipids for topical delivery of thymol: investigation of its anti-inflammatory properties

Nanostructured lipid carriers: promising drug delivery systems for future clinics

Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery

Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application

The authors are grateful to